ATAD1 and malaria: One study suggested that the risk of malaria is reduced only when IgG antibodies to MSP1–19 are present at very high titters [42]; however, more recent work concluded that only antibodies inhibiting the processing of MSP1, but not those directed to MSP1–19, were associated with protection [42,68].